RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
28 hedge funds and large institutions have $2.71M invested in Regulus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.53% less ownership
Funds ownership: 3% → 2.47% (-0.53%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
28
Holding in Top 10
–
Calls
–
Puts
$5K
Top Buyers
| 1 | +$118K | |
| 2 | +$68K | |
| 3 | +$64K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$11K |
Top Sellers
| 1 | -$183K | |
| 2 | -$25K | |
| 3 | -$21K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$21K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$10K |